Dallas, TX, October 07, 2010 --(PR.com
)-- ReportsandReports announce Genzyme Corporation: PharmaVitae Profile
Market Research Report in its Store.
Browse the complete Report at: Genzyme Corporation: PharmaVitae Profile
This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
Benchmark Genzyme's performance against key rivals in the prescription pharmaceutical sector
See how the company's core products of Cerezyme, Fabrazyme and Myozyme/Lumizyme will continue to act as the primary sales growth drivers
Assess the impact of the recent contamination of the Allston manufacturing facility on the company's performance through 2009
Browse all Healthcare Market Research Reports
Browse all Datamonitor Market Research Reports
Browse all Newly Published Market Research Reports http://www.reportsandreports.com/LatestReport.aspx
Original Source: PharmaVitae Market
Buy Now: Research
Genzyme Corporation Market Share Analysis
Genzyme Corporation-Deals & Alliances Report
Genzyme Corporation-Detailed Product Pipeline
Genzyme Corporation-Therapeutic Competitors
Genzyme Corporation - SWOT Analysis
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
7557 Rambler road,
Suite 727, Dallas, TX 75231